RCT | Novel autotaxin inhibitor Ziritaxestat shows no benefit for idiopathic pulmonary fibrosis
15 May, 2023 | 13:08h | UTCZiritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials – JAMA (free for a limited period)